✦ LIBER ✦

Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy

✍ Scribed by Michael Boyiadzis; Robert L. Redner; Anastasios Raptis; Jing-Zhou Hou; Mounzer Agha; Kenneth A. Foon

Publisher: Springer
Year: 2010
Tongue: English
Weight: 71 KB
Volume: 90
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-010-1076-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase 2 study of combination therapy w

A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia

✍ Mikkael A. Sekeres; Jaroslaw P. Maciejewski; Harry P. Erba; Manuel Afable; Ricki 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

Gemtuzumab ozogamicin with cytarabine an

Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience

✍ G. Specchia; D. Pastore; P. Carluccio; G. Spinosa; M. Giannoccaro; R. Rizzi; A. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 95 KB

AAML03P1, a pilot study of the safety of

AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia : A report from the Children's Oncology Group

✍ Todd M. Cooper; Janet Franklin; Robert B. Gerbing; Todd A. Alonzo; Craig Hurwitz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 385 KB 👁 2 views

Final report of the efficacy and safety

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence

✍ Richard A. Larson; Eric L. Sievers; Edward A. Stadtmauer; Bob Löwenberg; Elihu H 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 1 views

Impact of socioeconomic status and dista

Impact of socioeconomic status and distance from treatment center on survival in patients receiving remission induction therapy for newly diagnosed acute myeloid leukemia

✍ Cristina P. Rodriguez; Rachid Baz; Rony Abou Jawde; Lisa A. Rybicki; Matt E. Kal 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 136 KB

A randomized trial of continuous infusio

A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia

✍ Yener Koc; Basak Oyan; Ayse Kars; Gulten Tekuzman; Hande Canpinar; Emin Kansu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

## Abstract Mitoxantrone (MTZ) has been shown to be effective in the treatment of newly diagnosed acute myeloblastic leukemia (AML). The objective of this randomized study was to evaluate the impact of mode of administration of MTZ on the response and recurrence rates in newly diagnosed patients wi